📣 VC round data is live. Check it out!
- Public Comps
- EBM Technologies
EBM Technologies Valuation Multiples
Discover revenue and EBITDA valuation multiples for EBM Technologies and similar public comparables like Diagnos, Micro-X, MRSO, CareView Communications and more.
EBM Technologies Overview
About EBM Technologies
EBM Technologies Inc is engaged in picture archiving and communication systems. Its products include EBM diagnostic and reviewing station, EBM storage and utility server, and EBM breast imaging for PACS. The company develops and markets medical information technology solutions; and provides to the health sector.
Founded
1988
HQ

Employees
116
Website
Financials (FY)
EV
$17M
Valuation Multiples
Start free trialEBM Technologies Financials
EBM Technologies reported last fiscal year revenue of $8M and EBITDA of $913K.
In the same fiscal year, EBM Technologies generated $6M in gross profit, $913K in EBITDA, and $249K in net income.
EBM Technologies P&L
In the most recent fiscal year, EBM Technologies reported revenue of $8M and EBITDA of $913K.
EBM Technologies is profitable as of last fiscal year, with gross margin of 69%, EBITDA margin of 11%, and net margin of 3%.
Financial data powered by Morningstar, Inc.
EBM Technologies Stock Performance
EBM Technologies has current market cap of $20M, and enterprise value of $17M.
Market Cap Evolution
EBM Technologies' stock price is $0.61.
EBM Technologies share price increased by 0.5% in the last 30 days, and decreased by 17.3% in the last year.
EBM Technologies has an EPS (earnings per share) of $0.01.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $17M | $20M | 1.1% | 0.5% | -5.6% | -17.3% | $0.01 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialEBM Technologies Valuation Multiples
EBM Technologies trades at 2.2x EV/Revenue multiple, and 19.1x EV/EBITDA.
EBM Technologies Financial Valuation Multiples
As of June 4, 2026, EBM Technologies has market cap of $20M and EV of $17M.
EBM Technologies has a P/E ratio of 78.4x.
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified EBM Technologies Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


EBM Technologies Margins & Growth Rates
In the most recent fiscal year, EBM Technologies reported gross margin of 69%, EBITDA margin of 11%, and net margin of 3%.
EBM Technologies Margins
EBM Technologies Growth Rates
Data powered by FactSet, Inc. and Morningstar, Inc.
EBM Technologies Operational KPIs
EBM Technologies' revenue per employee in the last FY averaged $0.1M, while opex per employee averaged $0.0M for the same period.
Data powered by FactSet, Inc. and Morningstar, Inc.
EBM Technologies Competitors
EBM Technologies competitors include Diagnos, Micro-X, MRSO, CareView Communications, SenzaGen, NextPlat, Biosynex, CurveBeam AI, Cambridge Cognition and Metacare.
Most EBM Technologies public comparables operate across Healthcare Software, Medical Imaging & Diagnostics, B2B SaaS, HealthTech and Vertical SaaS.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| 243.5x | - | (7.1x) | - | |||
| 2.0x | 1.0x | (2.4x) | (4.7x) | |||
| 1.2x | 1.2x | (44.7x) | - | |||
| - | - | - | - | |||
| 2.6x | - | (18.1x) | - | |||
| 0.2x | - | (1.3x) | - | |||
| 0.8x | - | 60.1x | - | |||
| 2.9x | 3.2x | (3.5x) | (3.5x) | |||
This data is available for Pro users. Sign up to see all EBM Technologies competitors and their valuation data. Start Free Trial | ||||||
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout EBM Technologies
| When was EBM Technologies founded? | EBM Technologies was founded in 1988. |
| Where is EBM Technologies headquartered? | EBM Technologies is headquartered in Taiwan. |
| How many employees does EBM Technologies have? | As of today, EBM Technologies has over 116 employees. |
| Is EBM Technologies publicly listed? | Yes, EBM Technologies is a public company listed on Taipei Exchange. |
| What is the stock symbol of EBM Technologies? | EBM Technologies trades under 8409 ticker. |
| When did EBM Technologies go public? | EBM Technologies went public in 2012. |
| Who are competitors of EBM Technologies? | EBM Technologies main competitors include Diagnos, Micro-X, MRSO, CareView Communications, SenzaGen, NextPlat, Biosynex, CurveBeam AI, Cambridge Cognition, Metacare. |
| What is the current market cap of EBM Technologies? | EBM Technologies' current market cap is $20M. |
| What is the current revenue of EBM Technologies? | EBM Technologies' last fiscal year revenue is $8M. |
| What is the current EV/Revenue multiple of EBM Technologies? | Current revenue multiple of EBM Technologies is 2.2x. |
| Is EBM Technologies profitable? | No, EBM Technologies is not profitable. |
| How many companies EBM Technologies has acquired to date? | EBM Technologies hasn't acquired any companies yet (or none have been disclosed publicly). |
| In how many companies EBM Technologies has invested to date? | EBM Technologies hasn't invested in any companies yet (or none have been disclosed publicly). |
See public comps similar to EBM Technologies
Lists including EBM Technologies
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.